Emerging Growth Medical Company
As the Biden administration takes office, the writer also notes additional companies that may come into play with potential regulatory changes, including Constellation Brands (NYSE:STZ), which holds a stake in Canopy Growth (NASDAQ:CGC). Other companies noted to potentially expand into the cannabis market include tobacco company Altria (NYSE:MO), and beverage companies Anheuser-Busch InBev (NYSE:BUD) and Molson-Coors (NYSE:TAP).
LAS VEGAS, NV / ACCESSWIRE / January 19, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as...
Petco Health and Wellness Company (NASDAQ: WOOF) launched its third IPO in Company history last Thursday, and this time, according to CNN Business, It’s taking...
One of the essential elements in the extracts vertical advancements is the adoption of good manufacturing practices. According to the World Health Organization website, “Good Manufacturing Practice (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use.”
Total revenues were $4,907,889 compared to $3,056,431 reported in the same quarter in 2019, representing an increase of over 61%, and a 29.8% increase over the first fiscal quarter of 2021. Gross margin increased to 55% - an increase of 7% over the quarter ended November 30, 2019.
Companies that trade on major exchanges have a far better chance of receiving coverage from independent research firms and investment banks, which will ultimately help drive market and investment activity in a particular stock. Most independent research firms and investment banks however do not provide coverage for companies trading on the OTC markets.
PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment
Generex (GNBT) and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine, Files Trademark Application
ISW Holdings (ISWH) Announces Acquisition Plans in Telehealth and Home Healthcare Segment, Targets 500% Topline Growth in 2021